There was a panel discussion on the "PV Guidance Document for MAHs of Pharmaceutical Products" recently released by PvPI. The session was moderated by Dr P S Karthik Babu – Affiliate Pharmacovigilance Head, Sanofi, and saw representation from the CDSCO, foreign multinationals, and Indian companies who engaged in an enriching discussion on the timeframe for implementation of the guidelines, expectations, interpretations, challenges and acceptability from various sections of the audience.